The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The Emerging Risk of Peptides in Supplements LegitScript The FDA's Current Position on Peptides Explained Holt Law BPC 157 Weight Loss: Evidence & Safety The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The Emerging Risk of Peptides in Supplements LegitScript